Clene Company Leadership

CLNN Stock  USD 6.40  0.43  7.20%   
Clene's insiders are aggressively selling. The analysis of the overall insider sentiment regarding Clene Inc suggests that virtually all insiders are panicking. Clene employs about 75 people. The company is managed by 10 executives with a total tenure of roughly 175 years, averaging almost 17.0 years of service per executive, having 7.5 employees per reported executive.

Insider Sentiment 0

 Mostly Selling

 
Selling
 
Buying

Latest Trades

2025-08-21General Resonance LlcDisposed 3401 @ 5.34View
2025-05-27General Resonance LlcDisposed 420 @ 2.45View
2025-03-18General Resonance LlcDisposed 1333 @ 4.45View
Monitoring Clene's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clene Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

Clene's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Clene's future performance. Based on our forecasts, it is anticipated that Clene will maintain a workforce of about 80 employees by February 2026.
 
Covid

Clene Management Team Effectiveness

The company has return on total asset (ROA) of (0.5624) % which means that it has lost $0.5624 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (17.3836) %, meaning that it created substantial loss on money invested by shareholders. Clene's management efficiency ratios could be used to measure how well Clene manages its routine affairs as well as how well it operates its assets and liabilities. As of the 10th of January 2026, Return On Equity is likely to grow to 4.20, though Return On Tangible Assets are likely to grow to (1.57). At this time, Clene's Fixed Asset Turnover is very stable compared to the past year.
As of the 10th of January 2026, Common Stock Shares Outstanding is likely to drop to about 4.4 M. In addition to that, Net Loss is likely to drop to about (28.3 M)
The market capitalization of Clene Inc is $61.69 Million. Clene Inc retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
 
Shares in Circulation  
First Issued
2019-03-31
Previous Quarter
9.5 M
Current Value
10.3 M
Avarage Shares Outstanding
4.8 M
Quarterly Volatility
2.2 M
 
Covid
Some institutional investors establish a significant position in stocks such as Clene in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Clene, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Clene Workforce Comparison

Clene Inc is rated fourth in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 924. Clene holds roughly 75.0 in number of employees claiming about 8% of equities under Health Care industry.

Clene Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Clene insiders, such as employees or executives, is commonly permitted as long as it does not rely on Clene's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Clene insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2025-12-01
0.4286
9
21
 444,237 
 729,102 
2025-09-01
16.0
16
1
 239,063 
 3,401 
2025-06-01
2.6667
16
6
 66,974 
 2,860 
2025-03-01
5.5
11
2
 135,305 
 2,733 
2024-06-01
3.6667
22
6
 7,543,893 
 58,500 
2023-09-01
1.5
6
4
 198,901 
 90,000 
2022-09-01
7.0
7
1
 76,596 
 23,483 
2022-06-01
3.2
16
5
 662,020 
 439,673 
2022-03-01
4.75
19
4
 1,878,426 
 627,546 
2021-12-01
11.0
22
2
 5,211,340 
 60,000 
2021-09-01
11.0
11
1
 88,355 
 1,635 
2021-06-01
45.0
45
1
 2,131,845 
 12,500 

Clene Notable Stakeholders

A Clene stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Clene often face trade-offs trying to please all of them. Clene's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Clene's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Robert MBAPresident CEOProfile
Robert MDChief OfficerProfile
CPA CPAChief OfficerProfile
Tae MgtConsultantProfile
Mark ESQChief OfficerProfile
Michael HotchkinChief OfficerProfile
Mark MortensonCoFounder OfficerProfile
Mary McneilHead ResourcesProfile
MHS MDHead MedicalProfile
Jerry JDGeneral SecretaryProfile
String symbol = request.getParameter("s");

About Clene Management Performance

The success or failure of an entity such as Clene Inc often depends on how effective the management is. Clene management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Clene management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Clene management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(1.66)(1.57)
Return On Capital Employed(2.23)(2.34)
Return On Assets(1.66)(1.57)
Return On Equity 4.00  4.20 

Clene Workforce Analysis

Traditionally, organizations such as Clene use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Clene within its industry.

Clene Manpower Efficiency

Return on Clene Manpower

Revenue Per Employee4.6K
Revenue Per Executive34.2K
Net Loss Per Employee525.3K
Net Loss Per Executive3.9M
Working Capital Per Employee78.2K
Working Capital Per Executive586.6K
When determining whether Clene Inc is a strong investment it is important to analyze Clene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Clene's future performance. For an informed investment choice regarding Clene Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clene Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clene. If investors know Clene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.614
Earnings Share
(3.44)
Revenue Per Share
0.023
Quarterly Revenue Growth
(0.83)
Return On Assets
(0.56)
The market value of Clene Inc is measured differently than its book value, which is the value of Clene that is recorded on the company's balance sheet. Investors also form their own opinion of Clene's value that differs from its market value or its book value, called intrinsic value, which is Clene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clene's market value can be influenced by many factors that don't directly affect Clene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.